Search

Your search keyword '"Bernacchia, D"' showing total 29 results

Search Constraints

Start Over You searched for: Author "Bernacchia, D" Remove constraint Author: "Bernacchia, D"
29 results on '"Bernacchia, D"'

Search Results

1. Surge of Mpox cases in Lombardy region, Italy, October 2023 - January 2024

3. The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort

4. The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort

5. Human immunodeficiency virus continuum of care in 11 european union countries at the end of 2016 overall and by key population: Have we made progress?

6. Virological response and retention in care according to time of starting ART in Italy: Data from the Icona Foundation Study cohort

7. Human Immunodeficiency Virus Continuum of Care in 11 European Union Countries at the End of 2016 Overall and by Key Population: Have We Made Progress?

8. Evaluation of HIV transmission clusters among natives and foreigners living in Italy

9. Virological response and retention in care according to time of starting ART in Italy: data from the Icona Foundation Study cohort

10. Impact of diabetes on the risk of serious liver events and liver-related deaths in people living with HIV and hepatitis C co-infection: data from the ICONA Foundation Cohort Study

11. Impact of diabetes on the risk of serious liver events and liver-related deaths in people living with HIV and hepatitis C co-infection: data from the ICONA Foundation Cohort Study

12. HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects from the ICONA Italian Cohort of HIV-Infected Patients

13. Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort

14. Switching from TDF to TAF or dual therapy (DT)-based regimens in HIV-infected individuals with viral load <= 50 copies/ml: does eGFR matter?

16. Serius liver events and liver-related deaths in HIV/HCV co.infected patients with diabetes: data from the ICONA Founfation Cohort Study

18. Use of TAF with a HIV-RNA <50 cp/mL in clinical practice

19. Self-Reported Symptoms of SARS-CoV-2 Infection in a Nonhospitalized Population in Italy: Cross-Sectional Study of the EPICOVID19 Web-Based Survey

20. Surge of Mpox cases in Lombardy region, Italy, October 2023 - January 2024.

22. A case of extremely prolonged viral shedding: Could cell cultures be a diagnostic tool to drive COVID-19 patient discharge?

23. Prevalence of SARS-CoV-2 in an area of unrestricted viral circulation: Mass seroepidemiological screening in Castiglione d'Adda, Italy.

25. Genomic characterization and phylogenetic analysis of SARS-COV-2 in Italy.

26. 30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: A prospective cohort study.

27. Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study.

28. Darunavir does not prevent SARS-CoV-2 infection in HIV patients.

29. Impact of diabetes on the risk of serious liver events and liver-related deaths in people living with HIV and hepatitis C co-infection: data from the ICONA Foundation Cohort Study.

Catalog

Books, media, physical & digital resources